<DOC>
	<DOCNO>NCT00195208</DOCNO>
	<brief_summary>The purpose study demonstrate pharmacodynamic comparability pantoprazole spheroid formulation market tablet formulation .</brief_summary>
	<brief_title>Study Comparing Pantoprazole Formulation Currently Marketed Tablet GERD Erosive Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>GERD history Erosive Esophagitis document endoscopy H. pylorus negative Gastrointestinal condition esophageal stricture , esophageal varix , previous vagotomy Achlorhydria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Gastroesophageal Reflux Disease ( GERD )</keyword>
</DOC>